1.
Gibbs RA, Rogers J, Katze MG et al. Evolutionary and biomedical insights from the
rhesus macaque genome. Science (New York, NY). 2007;316:222-34.
2.
Simmons HA. Age-Associated Pathology in Rhesus Macaques (Macaca mulatta). Veterinary
pathology. 2016;53:399-416.
3.
Roth GS, Mattison JA, Ottinger MA et al. Aging in rhesus monkeys: relevance to human
health interventions. Science (New York, NY). 2004;305:1423-6.
4.
Sloane JA, Pietropaolo MF, Rosene DL et al. Lack of correlation between plaque burden
and cognition in the aged monkey. Acta neuropathologica. 1997;94:471-8.
5.
Fan X, Wheatley EG, Villeda SA. Mechanisms of Hippocampal Aging and the Potential
for Rejuvenation. Annual review of neuroscience. 2017;40:251-72.
6.
Vanduffel W. Long-term value memory in primates. Proceedings of the National Academy
of Sciences of the United States of America. 2018;115:1956-8.
7.
Lynch MA. Long-term potentiation and memory. Physiological reviews. 2004;84:87-136.
8.
Bartus RT, Fleming D, Johnson HR. Aging in the rhesus monkey: debilitating effects
on short-term memory. Journal of gerontology. 1978;33:858-71.
9.
Moss MB, Killiany RJ, Lai ZC et al. Recognition memory span in rhesus monkeys of advanced
age. Neurobiology of aging. 1997;18:13-9.
10.
Hara Y, Rapp PR, Morrison JH. Neuronal and morphological bases of cognitive decline
in aged rhesus monkeys. Age (Dordrecht, Netherlands). 2012;34:1051-73.
11.
Shamy JL, Buonocore MH, Makaron LM et al. Hippocampal volume is preserved and fails
to predict recognition memory impairment in aged rhesus monkeys (Macaca mulatta).
Neurobiology of aging. 2006;27:1405-15.
12.
Shamy JL, Habeck C, Hof PR et al. Volumetric correlates of spatiotemporal working
and recognition memory impairment in aged rhesus monkeys. Cerebral cortex (New York,
NY : 1991). 2011;21:1559-73.
13.
Noda A, Ohba H, Kakiuchi T et al. Age-related changes in cerebral blood flow and glucose
metabolism in conscious rhesus monkeys. Brain research. 2002;936:76-81.
14.
Xu B, Gao Y, Zhan S et al. Quantitative protein profiling of hippocampus during human
aging. Neurobiol Aging. 2016;39:46-56.
15.
Dolcos F, Rice HJ, Cabeza R. Hemispheric asymmetry and aging: right hemisphere decline
or asymmetry reduction. Neuroscience and biobehavioral reviews. 2002;26:819-25.
16.
Vizcaíno JA, Deutsch EW, Wang R et al. ProteomeXchange provides globally coordinated
proteomics data submission and dissemination. Nature biotechnology. 2014;32:223.
17.
McCarroll SA, Murphy CT, Zou S et al. Comparing genomic expression patterns across
species identifies shared transcriptional profile in aging. Nature genetics. 2004;36:197-204.
18.
Dillin A, Hsu AL, Arantes-Oliveira N et al. Rates of behavior and aging specified
by mitochondrial function during development. Science (New York, NY). 2002;298:2398-401.
19.
Feng J, Bussiere F, Hekimi S. Mitochondrial electron transport is a key determinant
of life span in Caenorhabditis elegans. Developmental cell. 2001;1:633-44.
20.
Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell. 2005;120:483-95.
21.
Bowling AC, Mutisya EM, Walker LC et al. Age-dependent impairment of mitochondrial
function in primate brain. Journal of neurochemistry. 1993;60:1964-7.
22.
Choi EJ, Chen W, Jun K et al. Novel brain arteriovenous malformation mouse models
for type 1 hereditary hemorrhagic telangiectasia. PLoS One. 2014;9:e88511.
23.
Scialo F, Sriram A, Fernandez-Ayala D et al. Mitochondrial ROS Produced via Reverse
Electron Transport Extend Animal Lifespan. Cell metabolism. 2016;23:725-34.
24.
Kwon YY, Choi KM, Cho C et al. Mitochondrial Efficiency-Dependent Viability of Saccharomyces
cerevisiae Mutants Carrying Individual Electron Transport Chain Component Deletions.
Mol Cells. 2015;38:1054-63.
25.
Ghosh S, Lertwattanarak R, Lefort N et al. Reduction in reactive oxygen species production
by mitochondria from elderly subjects with normal and impaired glucose tolerance.
Diabetes. 2011;60:2051-60.
26.
Stauch KL, Purnell PR, Villeneuve LM et al. Proteomic analysis and functional characterization
of mouse brain mitochondria during aging reveal alterations in energy metabolism.
Proteomics. 2015;15:1574-86.
27.
Silva-Palacios A, Ostolga-Chavarria M, Zazueta C et al. Nrf2: Molecular and epigenetic
regulation during aging. Ageing research reviews. 2018;47:31-40.
28.
Kubben N, Zhang W, Wang L et al. Repression of the Antioxidant NRF2 Pathway in Premature
Aging. Cell. 2016;165:1361-74.
29.
Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation
in cellular signaling. Cellular signalling. 2012;24:981-90.
30.
DeNicola GM, Karreth FA, Humpton TJ et al. Oncogene-induced Nrf2 transcription promotes
ROS detoxification and tumorigenesis. Nature. 2011;475:106-9.
31.
Dwivedi S, Rajasekar N, Hanif K et al. Sulforaphane Ameliorates Okadaic Acid-Induced
Memory Impairment in Rats by Activating the Nrf2/HO-1 Antioxidant Pathway. Molecular
neurobiology. 2016;53:5310-23.
32.
Li XH, Li CY, Lu JM et al. Allicin ameliorates cognitive deficits ageing-induced learning
and memory deficits through enhancing of Nrf2 antioxidant signaling pathways. Neuroscience
letters. 2012;514:46-50.
33.
Zhang H, Davies KJA, Forman HJ. Oxidative stress response and Nrf2 signaling in aging.
Free radical biology & medicine. 2015;88:314-36.
34.
Chhunchha B, Singh P, Stamer WD et al. Prdx6 retards senescence and restores trabecular
meshwork cell health by regulating reactive oxygen species. Cell death discovery. 2017;3:17060.
35.
Behndig A. Corneal endothelial integrity in aging mice lacking superoxide dismutase-1
and/or superoxide dismutase-3. Molecular vision. 2008;14:2025-30.
36.
Kwon MJ, Lee KY, Lee HW et al. SOD3 Variant, R213G, Altered SOD3 Function, Leading
to ROS-Mediated Inflammation and Damage in Multiple Organs of Premature Aging Mice.
Antioxidants & redox signaling. 2015;23:985-99.
37.
Tsvetkov P, Adamovich Y, Elliott E et al. E3 ligase STUB1/CHIP regulates NAD(P)H:quinone
oxidoreductase 1 (NQO1) accumulation in aged brain, a process impaired in certain
Alzheimer disease patients. The Journal of biological chemistry. 2011;286:8839-45.
38.
Jiang L, Kon N, Li T et al. Ferroptosis as a p53-mediated activity during tumour suppression.
Nature. 2015;520:57-62.
39.
Li T, Liu X, Jiang L et al. Loss of p53-mediated cell-cycle arrest, senescence and
apoptosis promotes genomic instability and premature aging. Oncotarget. 2016;7:11838-49.
40.
Jeng W, Loniewska MM, Wells PG. Brain glucose-6-phosphate dehydrogenase protects against
endogenous oxidative DNA damage and neurodegeneration in aged mice. ACS chemical neuroscience. 2013;4:1123-32.
41.
Nobrega-Pereira S, Fernandez-Marcos PJ, Brioche T et al. G6PD protects from oxidative
damage and improves healthspan in mice. Nature communications. 2016;7:10894.
42.
Wolfson M, Budovsky A, Tacutu R et al. The signaling hubs at the crossroad of longevity
and age-related disease networks. The international journal of biochemistry & cell
biology. 2009;41:516-20.
43.
Yue JK, Vassar MJ, Lingsma HF et al. Transforming Research and Clinical Knowledge
in Traumatic Brain Injury Pilot: Multicenter Implementation of the Common Data Elements
for Traumatic Brain Injury. Journal of Neurotrauma. 2013;30:1831-44.
44.
Johnson SC, Rabinovitch PS, Kaeberlein M. mTOR is a key modulator of ageing and age-related
disease. Nature. 2013;493:338-45.
45.
Xu S, Cai Y, Wei Y. mTOR Signaling from Cellular Senescence to Organismal Aging. Aging
and disease. 2014;5:263-73.
46.
Hamlin CR, Kohn RR. Evidence for progressive, age-related structural changes in post-mature
human collagen. Biochimica et biophysica acta. 1971;236:458-67.
47.
Vafaie F, Yin H, O'Neil C et al. Collagenase-resistant collagen promotes mouse aging
and vascular cell senescence. Aging cell. 2014;13:121-30.
48.
Cho KA, Ryu SJ, Oh YS et al. Morphological adjustment of senescent cells by modulating
caveolin-1 status. The Journal of biological chemistry. 2004;279:42270-8.
49.
Yu DM, Jung SH, An HT et al. Caveolin-1 deficiency induces premature senescence with
mitochondrial dysfunction. Aging cell. 2017;16:773-84.
50.
Johnson TE. Caenorhabditis elegans 2007: the premier model for the study of aging.
Experimental gerontology. 2008;43:1-4.
51.
Kenyon CJ. The genetics of ageing. Nature. 2010;464:504-12.
52.
Uranga RM, Giusto NM, Salvador GA. Iron-induced oxidative injury differentially regulates
PI3K/Akt/GSK3beta pathway in synaptic endings from adult and aged rats. Toxicological
sciences : an official journal of the Society of Toxicology. 2009;111:331-44.
53.
Tzivion G, Hay N. PI3K-AKT-FoxO axis in cancer and aging. Biochimica et biophysica
acta. 2011;1813:1925.
54.
Costa-Mattioli M, Monteggia LM. mTOR complexes in neurodevelopmental and neuropsychiatric
disorders. Nature neuroscience. 2013;16:1537-43.
55.
Huang W, Zhu PJ, Zhang S et al. mTORC2 controls actin polymerization required for
consolidation of long-term memory. Nature neuroscience. 2013;16:441-8.
56.
Puighermanal E, Marsicano G, Busquets-Garcia A et al. Cannabinoid modulation of hippocampal
long-term memory is mediated by mTOR signaling. Nature neuroscience. 2009;12:1152-8.
57.
Jobim PF, Pedroso TR, Christoff RR et al. Inhibition of mTOR by rapamycin in the amygdala
or hippocampus impairs formation and reconsolidation of inhibitory avoidance memory.
Neurobiology of learning and memory. 2012;97:105-12.
58.
Tee AR, Manning BD, Roux PP et al. Tuberous sclerosis complex gene products, Tuberin
and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex
toward Rheb. Current biology : CB. 2003;13:1259-68.
59.
Kapahi P, Zid BM, Harper T et al. Regulation of lifespan in Drosophila by modulation
of genes in the TOR signaling pathway. Current biology : CB. 2004;14:885-90.
60.
Goorden SM, van Woerden GM, van der Weerd L et al. Cognitive deficits in Tsc1+/- mice
in the absence of cerebral lesions and seizures. Annals of neurology. 2007;62:648-55.
61.
Pan KZ, Palter JE, Rogers AN et al. Inhibition of mRNA translation extends lifespan
in Caenorhabditis elegans. Aging cell. 2007;6:111-9.
62.
Kapahi P, Chen D, Rogers AN et al. With TOR, less is more: a key role for the conserved
nutrient-sensing TOR pathway in aging. Cell metabolism. 2010;11:453-65.
63.
Klann E, Dever TE. Biochemical mechanisms for translational regulation in synaptic
plasticity. Nature reviews Neuroscience. 2004;5:931-42.
64.
Ma XM, Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nature
reviews Molecular cell biology. 2009;10:307-18.
65.
Graber TE, McCamphill PK, Sossin WS. A recollection of mTOR signaling in learning
and memory. Learning & memory (Cold Spring Harbor, NY). 2013;20:518-30.
66.
Yang F, Chu X, Yin M et al. mTOR and autophagy in normal brain aging and caloric restriction
ameliorating age-related cognition deficits. Behavioural brain research. 2014;264:82-90.
67.
Rattan SI. Synthesis, modifications, and turnover of proteins during aging. Experimental
gerontology. 1996;31:33-47.
68.
Sutton MA, Schuman EM. Dendritic protein synthesis, synaptic plasticity, and memory.
Cell. 2006;127:49-58.